Skip to main content
Elizabeth Puscheck, MD, Obstetrics & Gynecology, Hoffman Estates, IL, Highland Park Hospital

ElizabethEllaPuscheckMD

Obstetrics & Gynecology Hoffman Estates, IL

Reproductive Endocrinology & Infertility

Professor, Obstetrics & Gynecology, Wayne State University School of Medicine

Dr. Puscheck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Puscheck's full profile

Already have an account?

  • Office

    InVia Fertility
    1585 Barrington Road, Ste 406
    Hoffman Estates, IL 60169
    Phone+1 847-884-8884
    Fax+1 847-884-0924
  • Is this information wrong?

Education & Training

  • University of Tennessee
    University of TennesseeM.B.A., 2016 - 2016
  • Medical College of Georgia
    Medical College of GeorgiaFellowship, Reproductive Endocrinology and Infertility, 1991 - 1993
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 1987 - 1991
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1987
  • University of Chicago
    University of ChicagoM.S., Arts and Sciences Basic to Human Biology, 1983 - 1985
  • University of Chicago
    University of ChicagoA.B., Biology and Anthropology, Honors, 1979 - 1983

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1993 - 2026
  • MI State Medical License
    MI State Medical License 2000 - 2025
  • CA State Medical License
    CA State Medical License 1994 - 2025
  • GA State Medical License
    GA State Medical License 1991 - 1993
  • PA State Medical License
    PA State Medical License 1990 - 1992
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Super Doctor SuperDoctors.com
  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

PubMed

Authored Content

  • Predictors of Response for Elagolix with Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine FibroidsJuly 2020
  • Predictors of Response for Elagolix with Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine FibroidsJuly 2020
  • Predictors of Response for Elagolix with Add-Back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine FibroidsJuly 2020

Press Mentions

  • Research Finds Stress Reduces Viral Resistance Against COVID-19 in Embryonic Stem Cells
    Research Finds Stress Reduces Viral Resistance Against COVID-19 in Embryonic Stem CellsAugust 10th, 2021
  • AIUM Practice Parameter for the Performance of a Focused Ultrasound Examination in Reproductive Endocrinology and Female Infertility
    AIUM Practice Parameter for the Performance of a Focused Ultrasound Examination in Reproductive Endocrinology and Female InfertilityFebruary 13th, 2019

Grant Support

  • A phase 3 study to evaluate the safety and efficacy of Elagolix in combination with Estradiol/Northindrone Acetate in Subjects with Moderate Endometriosis.AbbVie2016–2023
  • A Randomized, double-blind, double-dummy, trial comparing MENOPUR solution for injection in a pre-filled pen and MENOPUR Powder and solvent for solution for injection (Menotropins for injection) in aFerring Pharmaceuticals2019–2021
  • A Randomized, double-blind, placebo-controlled, parallel groups, multicenter trial investigating the efficacy and safety of FE999049 in controlled ovarian stimulation in women aged 34-42 years undergoFerring Pharmaceuticals2018–2021
  • A Randomized, double-blind, placebo-controlled, parallel groups, multicenter trial investigating the efficacy and safety of FE999049 in controlled ovarian stimulation in women aged 18-34 years undergoFerring Pharmaceuticals2018–2021
  • Extension study to evaluate the efficacy and safety of Elagolix in premenopausal women with heavy menstrual bleeding associated with uterine fibroids.Abbvie2017–2020
  • A Phase 3, multicenter, randomized, double-blind, placebo-controlled study, investigating the efficacy and safety of daily oral administration of InvDrug alone and in combination with add-back therapyObseva2017–2020
  • WSU Cooperative Reproductive Medicine Network CenterNICHD2007–2019
  • Detroit Reproductive Career Development Research Center (WRHR)NIH/NICHD2011–2016

Committees

  • Gynecology Community Leader (Secretary- 2years, Vice Chair- 2years, then Chair -2 years), American Institute of Ultrasound in Medicine 2020 - Present

Professional Memberships

Hospital Affiliations